PARATHORMONARZNEIZUSAMMENSETZUNG

European patent · EP0735896 · Deleted

Register entry

Publication number
EP0735896
Application number
EP95903732
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Dec 16, 1994
Published
Oct 9, 1996
Granted
Oct 3, 2007
Deleted
Dec 15, 2014
Reason
Maximum term reached
IPC classes
A61K 38/29 (2006.01)
A61K 9/14 (2006.01)
A61K 47/12 (2006.01)
A61K 47/26 (2006.01)
Priority
US 172206 23.12.1993
PCT application
PCT/CA1994/000693 16.12.1994
PCT publication
WO1995/017207 29.06.1995
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 22, 2014

    Maximum term reached

    Published in Swissreg on 22.12.2014

  2. Sep 23, 2008

    Transferred

    Owner
    NPS Allelix Corp., c/o Blake, Cassels & Graydon LLP, 199 Bay Street, Suite 2800, Commerce Court West, Toronto, ON M5L 1A9, Canada → NPS Pharmaceuticals, Inc., 550 Hills Drive, 3rd Floor, Bedminster, NJ 07921, USA

    Published in Swissreg on 23.09.2008

  3. Nov 30, 2007

    Agent entered

    Representative
    Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49,, Postfach 2792, 8022 Zürich

    Published in +pat+ No 22 in 2007

  4. Oct 31, 2007

    Granted

    Published in +pat+ No 20 in 2007

Parties

Inventor

HOLTHUIS, Josephus, Johannes, Maria

NL-2333 AJ Leiden, NL

MEKKING, Albert

NL-3448 CR Woerden, NL

VOETMAN, Alwinus, Antonius

NL-1161 DT Zwanenburg, NL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.